Scholars Central

Conference abstractPublished 30 Mar 2021

NEUROPHYSIOLOGY 2021: Therapeutic effect of novel antidepressant drugs interfering with receptors of neurotransmitters and neuropeptides- Euro Akademie Pobneck, Germany

Authors: Felix-Martin Werner

Journal of Cognitive Neuropsychology

Volume 5 · Issue 2 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Major depression is a frequent psychiatric disease, which is mainly treated by different antidepressant drugs. However, one third of the depressive patients remain treatment-resistant. In major depression, in the brainstem, hippocampus and prefrontal cortex, alterations of neurotransmitters and neuropeptides and the belonging neural networks are updated. Starting from these findings, novel antidepressant drugs and combination of different antidepressant drugs are suggested. In the prefrontal cortex, glutamatergic neurons, which receive a postsynaptic excitatory potential from D2 dopaminergic neurons, exert a presynaptic inhibition upon M1 muscarinic cholinergic neurons via NMDA receptors. Medium spiny GABAergic/somatostatin neurons

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Cognitive Neuropsychology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cognitive Neuropsychology
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Felix-Martin Werner”